Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Lidocaine for POCD in Elderly Abdominal Surgery
NCT05502705Unknown
- Sponsor
- General Hospital of Ningxia Medical University
- Start
- Sep 2022
- Primary completion
- Sep 2024
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine in Post-operative cognitive dysfunction (POCD) (2 arms), sponsored by General Hospital of Ningxia Medical University. Primary endpoints: Changes from Baseline Brain-Derived Neurotrophic Factor at 3 days, Changes from Baseline Nerve Growth Factor at 3 days and 2 more. Status: unknown.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
Post-operative cognitive dysfunction (POCD)
Beyond the preview
Go deeper on NCT05502705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05502705.